Health ❯ Healthcare ❯ Medical Research ❯ Cancer Treatment

Immunotherapy

Cambridge Team Builds Two-Part Prodrug That Activates STING Only Inside Tumors

Peer-reviewed results in Nature Chemistry show tumor-restricted STING activation in engineered animal models.

Pumitamig Shows High Response in First-Line Small Cell Lung Cancer Phase 2

UCLA Details Off-the-Shelf CAR-NKT Therapy With Preclinical Success in Metastatic Kidney Cancer

TIM‑3 Triplet Therapy Shows Promise in Immunotherapy‑Resistant Melanoma Models

Intratumoral Fc-Optimized CD40 Antibody Achieves Systemic Remissions in Phase 1 Study

mRNA Neoantigen Vaccine Amplifies Anti-PD-1 Immunity and Suppresses Gastric Cancer Spread in Mice

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

Researchers Plan Trials to Counteract Sucralose’s Impairment of Cancer Immunotherapy

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

NHS Opens Pre-Treatment Immunotherapy Trial for Glioblastoma

Nature Study Shows Gut Bacterium YB328 Boosts Cancer Immunotherapy

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma

High-Dose Steroids Undermine Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Anti-CD30 therapy restores PD-1 immunotherapy efficacy in resistant skin cancers

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors

Study Reveals Key Barriers to TIL Therapy Success in Advanced Lung Cancer

Experimental Vaccine Keeps Kidney Cancer Patients Cancer-Free for Three Years

Innovative Antibody Shows Promise in Cancer Treatment

Immunotherapy Shows Long-Term Success in Treating Metastatic Melanoma

Experimental mRNA Vaccine Shows Promise in Early Cancer Trials